Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,751Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M71.2EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book5.310-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.6PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M32,400,032ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with XBI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
XBIFirst Eagle Investment 2016-03-31 Buy $45.73 - $70.2
($52.16)
$ 54.084%New holding18,150
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

XBI is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


XBI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Blackburn, AlainSenior Officer 2016-06-08Sell10,000$65.72-17.74view
Smith, DavidSenior Officer 2016-06-08Sell5,000$65.45-17.4view
Kovacevic, John GianniDirector, Senior Officer 2016-06-08Buy75,000$0.05108020view
Archer, PaulSenior Officer 2016-06-08Sell8,218$17218view
Turquoise Hill Resources Ltd.10% Security Holder 2016-06-08Sell375,000$0.2323404.35view
Miller, Ronald DouglasDirector 2016-06-08Sell4,000$13.5300.44view
Hibberd, Michael JohnDirector, Senior Officer 2016-06-08Buy200,000$0.0777128.57view
haukedal, peter lawrence10% Security Holder 2016-06-08Buy10,000$0.0867475view
Sider, Vance A.Senior Officer 2016-06-08Sell20,000$42.7426.49view
Donaldson, Christine MariaSenior Officer 2016-06-08Buy51$81.39-33.58view

Quarterly/Annual Reports about XBI:

    News about XBI:

    Articles On GuruFocus.com
    Value Investing in BioPharma Nov 18 2015 
    Are Earnings Important? These Days, Revenues Count for More! Mar 17 2014 

    More From Other Websites
    US GDP and Consumer Confidence: Is a Revival Coming? Jun 29 2016
    Brexit means little for biotech stocks, analyst says Jun 24 2016
    Traders Get It Right (Sort Of) With Leveraged Biotech ETFs Jun 22 2016
    Bio Tech; Market leader testing breakdown level Jun 21 2016
    Why Does XBI’s Loss Continue to Widen? Jun 16 2016
    Biotech: It's the Election, Silly Jun 15 2016
    Cellectar's stock soars after positive results of a study of its tumor treatment Jun 15 2016
    Biotech: Still Troubled Jun 14 2016
    How Are XBI’s Holdings’ Moving Averages Trending? Jun 13 2016
    Downside Ahead For Biotech Stocks? Jun 10 2016
    Yellen Upbeat on Economy: Wining Sector ETFs Jun 07 2016
    Biotech Bounce: Sizzle Or Fizzle? Jun 06 2016
    How Did Biotech ETFs Perform in the Week Ended June 3? Jun 06 2016
    Exelixis's stock surges after positive results from trial of kidney cancer treatment Jun 06 2016
    The buzz from ASCO Jun 03 2016
    ADP Unemployment Change Decent: Initial Jobless Claims Fall Jun 03 2016
    Here’s What Else Is Happening Now for Ionis Jun 03 2016
    6 Biotechs Seriously on the Move Jun 02 2016
    Biotech Stocks: Don't Expect a 'Miraculous Recovery' Jun 02 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)